Answers are grounded in this paper and cite their sources.
Endothelial cells (ECs) sustain high glycolytic flux and display remarkable metabolic plasticity. Although molecular pathways regulating endothelial glycolysis are well characterized, metabolic mechanisms underlying hypoxia-induced glycolytic activation during angiogenesis remain poorly understood. Here, we show that acetyl-CoA synthetase 2 (ACSS2) serves as a critical metabolic modulator, coupling acetate utilization with glycolytic flux to control EC function and angiogenesis. The high level of ACSS2-mediated acetate-to-acetyl-CoA conversion in angiogenic front ECs sustains acetyl-CoA levels, which are essential for EC proliferation and retinal vascularization. Conversely, endothelial-specific Acss2 deletion disrupts pathological angiogenesis and normalizes tumor vasculature. Mechanistically, ACSS2 maintains hypoxia-inducible factor 1α transcriptional activity and stabilizes glucose transporter 1, thereby preserving glycolysis. Pyruvate dehydrogenase kinase 4 knockdown rescues metabolic and functional defects in ACSS2-deficient ECs, revealing the vital role of acetyl-CoA homeostasis in modulating hypoxic endothelial metabolism. Taken together, these data establish ACSS2 as a pivotal regulator of vascular development and suggest that targeting acetate metabolism may be an effective way to modulate pathological angiogenesis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: